The impact of tranilast on restenosis after coronary angioplasty: The second tranilast restenosis following angioplasty trial (TREAT-2)-Reference-Cited by-同舟云学术

The impact of tranilast on restenosis after coronary angioplasty: The second tranilast restenosis following angioplasty trial (TREAT-2)

Published:2002-03 Issue:3 Volume:143 Page:506-513
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Tamai Hideo,Katoh Kazuzo,Yamaguchi Tetsu,Hayakawa Hirokazu,Kanmatsuse Katsuo,Haze Kazuo,Aizawa Tadanori,Nakanishi Shigemoto,Suzuki Shin,Suzuki Takahiko,Takase Shinichi,Nishikawa Hideo,Katoh Osamu

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute;Holmes;Am J Cardiol,1984

2. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients;Nobuyoshi;J Am Coll Cardiol,1988

3. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon: a quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months;Serruys;Circulation,1988

4. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease;Fishman;N Engl J Med,1994

5. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease;Serruys;N Engl J Med,1994

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the potential of tranilast: Targeting fibrotic signaling pathways for therapeutic benefit;International Immunopharmacology;2024-08

2. Inflammasomes as Potential Therapeutic Targets in Atherosclerotic Cardiovascular Disease;Endocrine, Metabolic & Immune Disorders - Drug Targets;2022-12

3. TRPV2 channel-based therapies in the cardiovascular field. Molecular underpinnings of clinically relevant therapies;Progress in Biophysics and Molecular Biology;2021-01

4. Targeting Smad-Mediated TGFß Pathway in Coronary Artery Bypass Graft;Journal of Cardiovascular Pharmacology and Therapeutics;2020-08-19

5. The quest for effective pharmacological suppression of neointimal hyperplasia;Current Problems in Surgery;2020-08